Announcements Trials
Browse Landscape Eligibility

Clinical Trials

6 trials
RecentStart dateEnrollment
AGuIX × Clear all

Phase

Phase 2 2Phase 1/2 2Phase 1 2

Status

Unknown 2Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 4Thoracic 1Gynecologic 1

Conditions

Brain Neoplasms 3Gynecologic Cancer 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 2848Cisplatin 2837Carboplatin 2635Radiotherapy 2522Paclitaxel 2424Gemcitabine 2263pembrolizumab 2099Docetaxel 1978Bevacizumab 1966Fluorouracil 1660Capecitabine 1640Oxaliplatin 1551Dexamethasone 1417Nivolumab 1394Doxorubicin 1349Rituximab 1338Magnetic Resonance Spectroscopy 1229Etoposide 1198Irinotecan 1122Leucovorin 1096Drug Therapy 1062Cytarabine 1010Pemetrexed 944fludarabine 933Specimen Handling 875Vincristine 857Prednisone 851Lenalidomide 838Trastuzumab 837Cetuximab 831

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT04789486 2025-05-23

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Dana-Farber Cancer Institute

Phase 1/2 Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04881032 2025-02-13

NANO-GBM

Centre Jean Perrin

Phase 1/2 Active not recruiting
66 enrolled
CNS

Glioblastoma

NCT03818386 2024-06-14

NANORAD2

University Hospital, Grenoble

Phase 2 Unknown
100 enrolled
CNS

Brain Neoplasms

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown
18 enrolled
Gynecologic

Gynecologic Cancer

NCT04094077 2021-06-08

NANOSTEREO

Centre Leon Berard

Phase 2 Terminated
1 enrolled
CNS

Brain Neoplasms

NCT02820454 2019-06-07

NANO-RAD

University Hospital, Grenoble

Phase 1 Completed
15 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡